Guidelines and Publications

Home Archive "Guidelines and Publications"
Updates to rules for Opioid Treatment Programs: The 42 CFR Part 8 Final Rule Table of Changes
Guidelines and Publications National Advocacy and Legislation

Updates to rules for Opioid Treatment Programs: The 42 CFR Part 8 Final Rule Table of Changes

The following table summarizes some key changes to 42 CFR part 8. This table does not discuss all changes. To review all of the changes to 42 CFR part 8, interested parties are encouraged to view the final rule. For questions regarding implementation of the final rule, please contact SAMHSA’s Division of Pharmacologic Therapies at 240-276-2700 or DPT@samhsa.hhs.gov or your State...
SAMHSA Updates Guidelines for Contingency Management: Incentives Increased to $750
Guidelines and Publications National Advocacy and Legislation

SAMHSA Updates Guidelines for Contingency Management: Incentives Increased to $750

Background CM is a health care intervention in which tangible reinforcers, or motivational incentives, are givento participants contingent on objective evidence of change in a specific, incentivized behavior. CM is widely studied and has been successful in treating a variety of SUDs in diverse populations, and with demonstrated long-term benefit (a median of 24 weeks after...
Engagement and Retention of Non-abstinent Patients in Substance Use Treatment
Guidelines and Publications

Engagement and Retention of Non-abstinent Patients in Substance Use Treatment

Clinical Consideration for Addiction Treatment Providers Background Initiation, engagement, and retention in treatment are critical factors that impact long-term outcomes for substance use disorders (SUDs); early treatment engagement and longer durations of treatment predict better clinical outcomes. Despite this, patients are regularly dissuaded from initiating treatment until they...
ASAM Guidelines on the Treatment of Stimulant Use Disorders
Guidelines and Publications

ASAM Guidelines on the Treatment of Stimulant use Disorders

About the Guideline Beyond overdose deaths, Stimulant Use Disorder (StUD) can cause a range of serious and long-term health problems, including cardiac, psychiatric, dental, and nutritional complications. Injection stimulant use increases the risk of contracting human immunodeficiency virus (HIV), viral hepatitis, and other infectious diseases such as infective endocarditis. The...